EXHIBIT 31.1

        CERTIFICATION PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A) UNDER
                THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

         I, Reinhard Schmidt, President and Chief Executive Officer of EP
MedSystems, Inc., certify that:

1.      I have reviewed this quarterly report on Form 10-Q of EP
        MedSystems, Inc.;

2.      Based on my knowledge, this report does not contain any untrue
        statement of a material fact or omit to state a material fact
        necessary to make the statements made, in light of the
        circumstances under which such statements were made, not
        misleading with respect to the period covered by this report;

3.      Based on my knowledge, the financial statements, and other
        financial information included in this report, fairly present in
        all material respects the financial condition, results of
        operations and cash flows of the small business issuer as of,
        and for, the periods presented in this report;

4.      The small business issuer's other certifying officers and I are
        responsible for establishing and maintaining disclosure controls
        and procedures (as defined in Exchange Act Rules 13a-15(e) and
        15d-15(e)) for the small business issuer and have:

        a)      Designed such disclosure controls and procedures, or caused such
                disclosure controls and procedures to be designed under our
                supervision, to ensure that material information relating to the
                small business issuer, including its consolidated subsidiaries,
                is made known to us by others within those entities,
                particularly during the period in which this report is being
                prepared;

        b)      [Paragraph omitted pursuant to SEC Release 33-8238];

        c)      Evaluated the effectiveness of the small business issuer's
                disclosure controls and procedures and presented in this report
                our conclusions about the effectiveness of the disclosure
                controls and procedures, as of the end of the period covered by
                this report based on such evaluation; and

        d)      Disclosed in this report any change in the small business
                issuer's internal control over financial reporting that occurred
                during the small business issuer's most recent fiscal quarter
                (the small business issuer's fourth fiscal quarter in the case
                of an annual report) that has materially affected, or is
                reasonably likely to materially affect, the small business
                issuer's internal control over financial reporting; and

5.      The small business issuer's other certifying officer(s) and I
        have disclosed, based on our most recent evaluation of internal
        control over financial reporting, to the small business issuer's
        auditors and the audit committee of the small business issuer's
        board of directors (or persons performing the equivalent functions):

        a)      All significant deficiencies and material weaknesses in the
                design or operation of internal control over financial reporting
                which are reasonably likely to adversely affect the small
                business issuer's ability to record, process, summarize and
                report financial information; and

        b)      Any fraud, whether or not material, that involves management or
                other employees who have a significant role in the small
                business issuer's internal control over financial reporting.

Date:  May 16, 2005                        /s/ Reinhard Schmidt
                                           -------------------------------------
                                           Reinhard Schmidt
                                           President and Chief Executive Officer
                                           (Principal Executive Officer)